A high OXPHOS CD8 T cell subset is predictive of immunotherapy resistance in melanoma patients.
Li C, Phoon YP, Karlinsey K, Tian YF, Thapaliya S, Thongkum A, Qu L, Matz AJ, Cameron M, Cameron C, Menoret A, Funchain P, Song JM, Diaz-Montero CM, Tamilselvan B, Golden JB, Cartwright M, Rodriguez A, Bonin C, Vella A, Zhou B, Gastman BR.
Li C, et al. Among authors: phoon yp.
J Exp Med. 2022 Jan 3;219(1):e20202084. doi: 10.1084/jem.20202084. Epub 2021 Nov 22.
J Exp Med. 2022.
PMID: 34807232
Free PMC article.